InterVivo Solutions

InterVivo Solutions is a pharmaceutical startup with a mission to advance translational drug discovery through the development and provision of translational animal models and transformative research services. Since its establishment in 2010, the company has focused on providing a natural aging canine model of human diseases, particularly Alzheimer's disease progression, cancer, osteoarthritis, obesity, and metabolic disorders. Additionally, they offer drug metabolism and pharmacokinetics screening, IND-enabling services, and various rodent models such as cognitive function, obesity, addiction, pain, epilepsy, and Parkinson’s disease. They also provide state-of-the-art imaging services and bioanalytical support. As of now, there is no publicly available information on their headquarters, last investment, or investors. InterVivo Solutions presents an intriguing opportunity for venture capital firms looking to invest in innovative solutions for improving the clinical success of new drugs.